These mycotoxins are commonly associated with promoting nephropathy and the risk off kidney disease
The phase 3 SELECT trial highlighted semaglutide 2.4 mgs capability to cut the risk of major adverse cardiovascular events by 20% in individuals with obesity compared to a placebo, leading to an updated label for Wegovy
There is currently no safety or efficacy data on microdosing, as no clinical trials have been conducted yet to test its effectiveness and long-term safety
doi: 10.1210/en.2003-1312
Protocol 3: Alternating days for sensitive skin Goal: Avoid layering conflicts entirely while building tolerance Day 1 (Vitamin C Day): AM: Cleanse, vitamin C serum, moisturize, sunscreen PM: Cleanse, hyaluronic acid , moisturize Day 2 (Peptide Day): AM: Cleanse, light serum, moisturize, sunscreen PM: Cleanse, peptide treatment, moisturize Notes: This approach works well for those new to active ingredients or with reactive skin that struggles with multiple actives
Please trust there is a difference